Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Cannabis

Avicanna's Colombian subsidiary Santa Marta Golden Hemp completes first export of feminized cannabis seeds to Spain

Avicanna Inc (TSX:AVCN, OTCQX:AVCNF) said its majority-owned Colombian subsidiary Santa Marta Golden Hemp SAS (SMGH) has completed its first commercial export of feminized cannabis seeds to Spain.

The company said the characterization and production of these seeds were completed through Avicanna’s vertical integration infrastructure at SMGH.

The seeds are a part of the Aureus portfolio of products which also includes proprietary genetics in the form of feminized seeds, cannabinoid extracts and purified compounds including CBD, CBG and THC, Avicanna added.

READ: Avicanna promotes Phillip Cardella to CFO effective immediately; closes placement raising around $1.77M

They are derived from hemp and cannabis cultivars and produced at the company’s industrial scale operations based in Santa Marta, Colombia.

Avicanna LATAM president Lucas Nosiglia said the company was pleased to announce that it had met the regulatory and quality standards of the Spanish authorities with the commercial export of its federally registered and standardized genetics.

“This marks the 19th country that our products have been exported to and we continue see the continued demand for our genetics program across international markets,” Nosiglia said.

“We look forward to expanding our genetic business unit in Spain and the rest of the European Union where demand for standardized genetics is growing with the emergence of the cannabis industry.”

Avicanna is a commercial-stage international biopharmaceutical company focused on the advancement and commercialization of evidence-based cannabinoid-based products for the global medical and pharmaceutical market segments.

Auerus, Avicanna’s supply chain business unit, is based in Santa Marta, Colombia, and provides a consistent source of cannabinoid raw materials for the global marketplace.

Contact the author at emily.jarvie@proactiveinvestors.com

Follow her on Twitter @emilyjjarvie

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK